Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...

NEW YORK – Galapagos said on Monday that it has partnered with NecstGen, a contract development and manufacturing organization (CDMO), to support decentralized manufacturing of Galapagos' cell therapy ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Now researchers explain why, by identifying specific changes in blood cells of people with Down ... Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep.

本研究首次描述了非洲血统 CLL 患者的白血病遗传和转录组特征。与欧洲血统 CLL 相比，非洲血统 CLL 具有更高的基因组复杂性，BRCC3、NOTCH1、NXF1 和 NFKBIE 等基因的突变患病率增加，同时存在 NF - κB 信号转录富集和端粒侵蚀增加的现象。

An international study of over 800 chronic lymphocytic leukemia (CLL) patients found that an all-tablet therapy of ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

A Cownose stingray at the Flordia Aquarium is being recognized as a part of the nationwide World Cancer Day celebration on ...

The molecular mechanisms underlying resistance to therapy in Chronic lymphocytic leukemia (CLL) remain to be explored. Here, the authors perform multi-omics analysis in a mouse model of ibrutinib ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...